Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||
| Net Income | 290 | 160 | -110 |
| Depreciation Amortization | 30 | 20 | 50 |
| Other Working Capital | -90 | -170 | -10 |
| Other Operating Activity | -170 | 30 | 50 |
| Operating Cash Flow | $60 | $40 | $-20 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -50 | -10 | -9 |
| Other Investing Activity | -10 | 0 | 9 |
| Investing Cash Flow | $-60 | $-10 | $0 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | -30 | 7 | 10 |
| Financing Cash Flow | $-30 | $7 | $10 |
| Beginning Cash Position | 40 | 8 | 10 |
| End Cash Position | 8 | 40 | 8 |
| Net Cash Flow | $-30 | $30 | $-9 |
| Free Cash Flow | |||
| Operating Cash Flow | 60 | 40 | -20 |
| Free Cash Flow | 60 | 40 | -20 |